Clinical Trial Update: Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CART-19 cell therapy for B cell acute lymphoblastic leukemia, reporting efficacy signals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CART-19 cell therapy

Snippet

Sponsor: Beijing Sanwater Biological Technology Co., Ltd. | Conditions: Acute Lymphoblastic Leukemia | Phase 1 | Status: UNKNOWN